$20m in financing for blood-based bowel cancer test

22 March 2016

Venture capital firm OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer.

Learn More

You may also like

12 January 2021

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

News, Media Release

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

27 May 2020

Clinical Genomics announces publication of Additional positive data reinforcing key benefits of COLVERA®

30 April 2020

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

View All

Ventured. Gained.

Subscribe to our Newsletter.

Name
decor
decor decor decor
decor decor decor decor decor